For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
2003
|
2002
|
|
Assets |
|
|
Current Assets |
79,945
|
73,721
|
Investments |
379,056
|
331,378
|
Assets Whose Use Is Limited |
1,055
|
1,055
|
Property, Plant, and Equipment, net |
223,723
|
218,304
|
Contributions Receivable, less current portion |
17,074
|
20,031
|
Other Assets |
9,102
|
7,853
|
Total Assets |
$709,955
|
$652,342
|
|
Liabilities and Net Assets |
|
|
Current Liabilities |
103,429
|
93,069
|
Long-Term Debt and Other Liabilities |
143,748
|
144,919
|
Net Assets |
|
|
Unrestricted |
217,306
|
198,526
|
Temporarily Restricted |
151,149
|
126,148
|
Permanently Restricted |
94,323
|
89,680
|
Subtotal Net Assets |
462,778
|
414,354
|
Total Liabilities and Net Assets |
$709,955
|
$652,342
|
|
Summary Statistical Information |
|
|
(Unless otherwise noted, includes adult and pediatric patients) |
2003
|
2002
|
Number of Licensed Beds (as of year end) |
27
|
27 |
Adult Inpatient Discharges |
947
|
991
|
Infusion Visits |
64,998
|
53,790
|
Outpatient MD Visits |
91,636
|
84,427
|
Clinical Trials (via Dana-Farber/Harvard Cancer Center) |
528
|
519
|
|
